Wyeth Renews and Expands License Agreement with Ingenuity Systems
Complete the form below to unlock access to ALL audio articles.
Ingenuity Systems has announced that it has entered an agreement with Wyeth to extend and expand its licensing agreement for access to IPA software.
Wyeth's research and development teams will utilize IPA in multiple research areas, including its pharmacogenomics group that focuses on approaches to identifying biomarkers.
"We are pleased that Wyeth has selected Ingenuity Systems as a key partner for its research programs," said Peter DiLaura, Senior Vice President of Commercial Operations at Ingenuity.
"Wyeth has been a valued customer since 2003, and we view this renewal as a testament to our ability to provide relevant and valuable solutions for researchers who need to analyze and understand the biological and chemical relationships within their experimental systems," DiLaura continued.
IPA is a software and content solution that provides insights and understanding of complex biological and chemical systems at the core of life science research.
